Aurobindo Pharma Ltd
NSE :AUROPHARMA BSE :524804 Sector : PharmaceuticalsBuy, Sell or Hold AUROPHARMA? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
22 Nov 1223.70 (0.30%) | 21 Nov 1220.00 (-2.41%) | 19 Nov 1250.10 (1.19%) | 18 Nov 1235.40 (-1.09%) | 14 Nov 1249.00 (-0.04%) | 13 Nov 1249.45 (-1.42%) | 12 Nov 1267.40 (-1.68%) | 11 Nov 1289.05 (-2.90%) | 08 Nov 1327.55 (-1.71%) | 07 Nov 1350.60 (-3.17%) | 06 Nov 1394.85 (-0.15%) | 05 Nov 1396.95 (-0.73%) | 04 Nov 1407.20 (0.46%) | 01 Nov 1400.70 (0.30%) | 31 Oct 1396.50 (-0.62%) | 30 Oct 1405.15 (-0.51%) | 29 Oct 1412.35 (-1.55%) | 28 Oct 1434.55 (0.45%) | 25 Oct 1428.15 (-0.97%) | 24 Oct 1442.20 (0.57%) | 23 Oct 1434.00 (-0.94%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Very Bearish
Medium Term Investors
Very Bearish
Long Term Investors
Neutral
Moving Averages
5 DMA
Bearish
1235.04
10 DMA
Bearish
1265.79
20 DMA
Bearish
1338.66
50 DMA
Bearish
1432.13
100 DMA
Bearish
1431.78
200 DMA
Bearish
1275.87
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On Nov 22, 2024 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 1247.34 | 1239.37 | 1228.05 | - | - |
R2 | 1239.37 | 1233.33 | 1226.6 | 1239.4 | - |
R1 | 1231.54 | 1229.61 | 1225.15 | 1231.6 | 1235.45 |
P | 1223.57 | 1223.57 | 1223.57 | 1223.6 | 1225.53 |
S1 | 1215.74 | 1217.53 | 1222.25 | 1215.8 | 1219.65 |
S2 | 1207.77 | 1213.81 | 1220.8 | 1207.8 | - |
S3 | 1199.94 | 1207.77 | 1219.36 | - | - |
Key Metrics
EPS
35.31
P/E
34.65
P/B
3.65
Dividend Yield
0.37%
Market Cap
71,701 Cr.
Face Value
1
Book Value
335.47
ROE
11.18%
EBITDA Growth
1,701.44 Cr.
Debt/Equity
0.21
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Aurobindo Pharma Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | |
INCOME | 7407.3 | 7514.3 | 7715.77 | 7787.95 | 7932.37 |
PROFIT | 757.18 | 936.29 | 974.2 | 919.22 | 817.38 |
EPS | 12.83 | 16.04 | 15.51 | 15.69 | 14 |
Aurobindo Pharma Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | |
INCOME | 2771.93 | 3023.16 | 3017 | 2525.41 | 2947.25 |
PROFIT | 379.65 | 623.78 | 578.67 | 329.04 | 537.53 |
EPS | 7.1 | 10.65 | 9.88 | 5.62 | 9.21 |
Profit & Loss (Figures in Rs. Crores)
Aurobindo Pharma Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 12546.71 | 14092.78 | 15339.65 | 17050.67 | 20397.12 | 23392.24 | 29135.18 | 23075.19 | 25555.65 | 30505.42 | |
PROFIT | 1587.14 | 2028.78 | 2306.24 | 2423.17 | 2430.63 | 2864.68 | 3410.14 | 2757.17 | 1919.7 | 3272.95 | |
EPS | 26.48 | 34.58 | 38.88 | 41.35 | 40.36 | 48.54 | 91.04 | 45.18 | 32.9 | 54.09 |
Aurobindo Pharma Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 8321.41 | 9496.13 | 9711.68 | 10684.73 | 12746.91 | 13998.23 | 16410.55 | 11912.62 | 9164.87 | 11431.97 | |
PROFIT | 1518.29 | 1627.51 | 1720.3 | 1812.82 | 1537.74 | 1878.78 | 3113.04 | 1535.98 | 1217.17 | 1952.97 | |
EPS | 25.54 | 27.8 | 28.73 | 30.94 | 26.11 | 32.03 | 53.13 | 24.83 | 20.94 | 33.35 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.52 | 29.2 |
Reserves Total | 29,784.21 | 26,781.26 | 24,517.39 | 21,871.28 | 16,766.08 | 13,832.19 | 11,621.83 | 9,313.32 | 7,228.78 | 5,126.71 |
Total Shareholders Funds | 29,842.8 | 26,839.85 | 24,575.98 | 21,929.87 | 16,824.67 | 13,890.78 | 11,680.42 | 9,371.91 | 7,287.3 | 5,155.91 |
Minority Interest | 8 | 12 | -1.93 | -0.88 | 0.14 | 1.59 | 1.82 | 2.08 | 2.55 | 25.82 |
Secured Loans | 3,968.37 | 2,557.37 | 543.69 | 1,053.55 | 1,314.97 | 1,661.87 | 419.18 | 640.8 | 2,285.15 | 2,081.94 |
Unsecured Loans | 2,679.26 | 2,728.84 | 2,307.58 | 4,285.53 | 4,511.41 | 5,304.89 | 4,350.75 | 2,723.34 | 2,755.92 | 2,369.13 |
Total Debt | 6,647.63 | 5,286.21 | 2,851.27 | 5,339.08 | 5,826.38 | 6,966.76 | 4,769.93 | 3,364.14 | 5,041.07 | 4,451.07 |
Other Liabilities | 277.59 | 214.26 | 212.91 | 250.71 | 162.19 | 80.16 | 66.43 | 39.13 | 23.36 | 24.35 |
Total Liabilities | 36,776.02 | 32,352.32 | 27,638.23 | 27,518.78 | 22,813.38 | 20,939.29 | 16,518.6 | 12,777.26 | 12,354.28 | 9,657.15 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 23,447.77 | 18,593.32 | 15,524.55 | 13,613.33 | 12,441.26 | 10,497.62 | 7,894.78 | 5,635.49 | 4,569.83 | 5,446.13 |
Less: Accumulated Depreciation | 8,954.98 | 7,569.63 | 4,992.46 | 4,239.75 | 3,044.79 | 2,022.77 | 1,374.1 | 801.71 | 390.14 | 1,740.49 |
Net Block | 14,492.79 | 11,023.69 | 10,532.09 | 9,373.58 | 9,396.47 | 8,474.85 | 6,520.68 | 4,833.78 | 4,179.69 | 3,705.64 |
Capital Work in Progress | 3,868.72 | 5,390.01 | 3,747.2 | 3,061.53 | 1,985.92 | 1,668.46 | 1,583.04 | 1,458.08 | 848.14 | 419.63 |
Investments | 372.23 | 542.74 | 997.15 | 591.01 | 554.71 | 360.22 | 311.54 | 245.87 | 122.96 | 19.79 |
Inventories | 9,810.47 | 8,516.11 | 7,559.08 | 9,041.18 | 7,699.87 | 7,245.6 | 5,858.41 | 4,330.54 | 4,056.14 | 3,611.3 |
Sundry Debtors | 4,816.74 | 4,466.38 | 4,012.26 | 3,503.28 | 4,315.16 | 3,413.78 | 3,080.2 | 2,765.33 | 4,606.68 | 3,539.17 |
Cash and Bank Balance | 6,278.3 | 6,084.2 | 4,190.01 | 5,474.28 | 2,842.15 | 1,957.18 | 1,262.25 | 513.48 | 800.26 | 469.11 |
Loans and Advances | 2,818.07 | 2,247.1 | 1,987.72 | 1,659.59 | 1,555.31 | 2,715.72 | 1,977.28 | 1,596.81 | 831.25 | 659.57 |
Total Current Assets | 23,723.58 | 21,313.79 | 17,749.07 | 19,678.33 | 16,412.49 | 15,332.28 | 12,178.14 | 9,206.16 | 10,294.33 | 8,279.15 |
Current Liabilities | 7,433.13 | 6,735.93 | 5,643.94 | 5,378.37 | 5,310.95 | 4,849.09 | 4,052.93 | 3,161.5 | 3,409.03 | 2,828.56 |
Provisions | 508.04 | 417.01 | 233.82 | 396.89 | 511.72 | 384.67 | 294.23 | 261.36 | 132.93 | 218.24 |
Total Current Liabilities & Provisions | 7,941.17 | 7,152.94 | 5,877.76 | 5,775.26 | 5,822.67 | 5,233.76 | 4,347.16 | 3,422.86 | 3,541.96 | 3,046.8 |
Net Current Assets | 15,782.41 | 14,160.85 | 11,871.31 | 13,903.07 | 10,589.82 | 10,098.52 | 7,830.98 | 5,783.3 | 6,752.37 | 5,232.35 |
Deferred Tax Assets | 1,335.71 | 768.88 | 429.74 | 600.91 | 163.2 | 183.29 | 539.17 | 501.82 | 227.37 | 33.3 |
Deferred Tax Liability | 479.63 | 481 | 552.11 | 722.79 | 291.69 | 281.31 | 615.65 | 383.36 | 45.05 | 239.08 |
Net Deferred Tax | 856.08 | 287.88 | -122.37 | -121.88 | -128.49 | -98.02 | -76.48 | 118.46 | 182.32 | -205.78 |
Other Assets | 1,403.79 | 947.15 | 612.85 | 711.47 | 414.95 | 435.26 | 348.84 | 337.77 | 268.8 | 485.52 |
Total Assets | 36,776.02 | 32,352.32 | 27,638.23 | 27,518.78 | 22,813.38 | 20,939.29 | 16,518.6 | 12,777.26 | 12,354.28 | 9,657.15 |
Contingent Liabilities | 311.34 | 158.53 | 157.74 | 140.83 | 145.98 | 133.71 | 211.79 | 196.97 | 177.11 | 195.38 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 | 58.52 | 29.2 |
Reserves Total | 19,664.23 | 17,975.44 | 17,058.75 | 15,866.02 | 12,993.91 | 11,292.03 | 9,923.99 | 8,377.59 | 6,807.33 | 5,330.34 |
Total Shareholders Funds | 19,722.82 | 18,034.03 | 17,117.34 | 15,924.61 | 13,052.5 | 11,350.62 | 9,982.58 | 8,436.18 | 6,865.85 | 5,359.54 |
Secured Loans | 1,431.99 | 1,922.78 | 288.75 | 841.5 | 1,314.36 | 1,594.43 | 376.19 | 498.65 | 1,002.71 | 1,884.01 |
Unsecured Loans | 1,428.75 | 2,280.38 | 1,606.14 | 3,200.46 | 2,427.1 | 2,925.37 | 3,342.81 | 2,555.26 | 3,162.72 | 1,400.72 |
Total Debt | 2,860.74 | 4,203.16 | 1,894.89 | 4,041.96 | 3,741.46 | 4,519.8 | 3,719 | 3,053.91 | 4,165.43 | 3,284.73 |
Other Liabilities | 46 | 87.31 | 5.03 | 0 | 42.68 | 22.64 | 33.6 | 20.87 | 21.26 | 22.65 |
Total Liabilities | 22,629.56 | 22,324.5 | 19,017.26 | 19,966.57 | 16,836.64 | 15,893.06 | 13,735.18 | 11,510.96 | 11,052.54 | 8,666.92 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 4,043.49 | 6,214.71 | 5,724.9 | 6,688.9 | 6,180.91 | 5,446.15 | 4,292.18 | 3,758.18 | 2,830.78 | 3,507.54 |
Less : Accumulated Depreciation | 1,624.36 | 2,527.21 | 2,139.07 | 2,216.83 | 1,763.11 | 1,296.45 | 899.21 | 546.56 | 262.65 | 1,317.53 |
Net Block | 2,419.13 | 3,687.5 | 3,585.83 | 4,472.07 | 4,417.8 | 4,149.7 | 3,392.97 | 3,211.62 | 2,568.13 | 2,190.01 |
Capital Work in Progress | 132.68 | 239.09 | 225.15 | 734.89 | 814.85 | 789.01 | 1,143.98 | 906.98 | 742.14 | 227.19 |
Investments | 13,393.44 | 8,105.37 | 6,584.36 | 5,009.93 | 2,527.41 | 2,339.06 | 1,967.5 | 1,681.95 | 1,183.35 | 1,012.75 |
Inventories | 2,367.6 | 4,125.26 | 3,356.18 | 4,841.38 | 4,359.57 | 3,971.26 | 3,409.23 | 2,433.62 | 2,431.6 | 2,145.05 |
Sundry Debtors | 3,776.59 | 4,560.26 | 3,973.24 | 5,928.01 | 5,785 | 5,232.07 | 4,468.23 | 3,773.63 | 4,380.97 | 3,708.94 |
Cash and Bank Balance | 94.34 | 373.41 | 50.78 | 386.18 | 86.16 | 75.77 | 245.9 | 33.64 | 330.81 | 11.13 |
Loans and Advances | 1,000.59 | 906.05 | 2,454.9 | 1,051.4 | 1,057.55 | 1,129.22 | 857.82 | 662.44 | 631.1 | 483.32 |
Total Current Assets | 7,239.12 | 9,964.98 | 9,835.1 | 12,206.97 | 11,288.28 | 10,408.32 | 8,981.18 | 6,903.33 | 7,774.48 | 6,348.44 |
Current Liabilities | 2,285.86 | 2,396.31 | 2,243.3 | 2,539.03 | 2,526.66 | 2,120.15 | 1,960.64 | 1,450.46 | 1,456.07 | 1,262.6 |
Provisions | 119.65 | 122.09 | 103.36 | 250.01 | 115.27 | 96.51 | 74.54 | 61.5 | 56.95 | 86.02 |
Total Current Liabilities & Provisions | 2,405.51 | 2,518.4 | 2,346.66 | 2,789.04 | 2,641.93 | 2,216.66 | 2,035.18 | 1,511.96 | 1,513.02 | 1,348.62 |
Net Current Assets | 4,833.61 | 7,446.58 | 7,488.44 | 9,417.93 | 8,646.35 | 8,191.66 | 6,946 | 5,391.37 | 6,261.46 | 4,999.82 |
Deferred Tax Assets | 47.45 | 55.24 | 43.82 | 68.61 | 411.92 | 439.87 | 382.06 | 333.52 | 267.97 | 28.55 |
Deferred Tax Liability | 166.36 | 271.15 | 280.85 | 501.99 | 496.96 | 470.87 | 405.54 | 333.44 | 261.11 | 238.89 |
Net Deferred Tax | -118.91 | -215.91 | -237.03 | -433.38 | -85.04 | -31 | -23.48 | 0.08 | 6.86 | -210.34 |
Other Assets | 1,969.61 | 3,061.87 | 1,370.51 | 765.13 | 515.27 | 454.63 | 308.21 | 318.96 | 290.6 | 447.49 |
Total Assets | 22,629.56 | 22,324.5 | 19,017.26 | 19,966.57 | 16,836.64 | 15,893.06 | 13,735.18 | 11,510.96 | 11,052.54 | 8,666.92 |
Contingent Liabilities | 1,969.15 | 534.26 | 152.93 | 770.1 | 2,006.56 | 2,496.37 | 1,214.54 | 427.41 | 799.8 | 558.92 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 4,379.99 |
Depreciation | 1,521.66 |
Interest (Net) | -17.67 |
P/L on Sales of Assets | -23.49 |
P/L on Sales of Invest | -0.1 |
Prov. and W/O (Net) | 52.53 |
P/L in Forex | -51.14 |
Total Adjustments (PBT and Ext... | 1,496.24 |
Operating Profit before Workin... | 5,876.23 |
Trade and 0ther Receivables | -264.19 |
Inventories | -1,303.68 |
Trade Payables | 582.84 |
Loans and Advances | -0.69 |
Total Adjustments (OP before W... | -1,675.07 |
Cash Generated from/(used in) ... | 4,201.16 |
Direct Taxes Paid | -1,766.64 |
Total Adjustments(Cash Generat... | -1,766.64 |
Cash Flow before Extraordinary... | 2,434.52 |
Net Cash from Operating Activi... | 2,434.52 |
Purchased of Fixed Assets | -3,561.5 |
Sale of Fixed Assets | 60.28 |
Purchase of Investments | -25.7 |
Sale of Investments | 179.15 |
Interest Received | 280.84 |
Net Cash used in Investing Act... | -4,241.78 |
Proceed from 0ther Long Term B... | 1,563.24 |
Of the Long Tem Borrowings | -17.17 |
Of the Short Term Borrowings | -84.76 |
Of Financial Liabilities | -146.6 |
Dividend Paid | -263.64 |
Interest Paid | -250.65 |
Net Cash used in Financing Act... | 800.42 |
Net Profit before Tax and Extr... | 2,475.41 |
Depreciation | 348.66 |
Interest (Net) | -15.89 |
Dividend Received | 264.67 |
P/L on Sales of Assets | -1.43 |
P/L on Sales of Invest | 30.07 |
Prov. and W/O (Net) | 11.11 |
P/L in Forex | -38.11 |
Total Adjustments (PBT and Ext... | 69.61 |
Operating Profit before Workin... | 2,545.02 |
Trade and 0ther Receivables | -743.59 |
Inventories | -308.34 |
Trade Payables | 751.9 |
Loans and Advances | -1.11 |
Total Adjustments (OP before W... | -228.04 |
Cash Generated from/(used in) ... | 2,316.98 |
Direct Taxes Paid | -602.18 |
Total Adjustments(Cash Generat... | -602.18 |
Cash Flow before Extraordinary... | 1,714.8 |
Net Cash from Operating Activi... | 1,714.8 |
Purchased of Fixed Assets | -426.75 |
Sale of Fixed Assets | 4.68 |
Purchase of Investments | -3,932.05 |
Sale of Investments | 11.92 |
Interest Received | 199.51 |
Loans to Subsidiaires | -2,345.35 |
Net Cash used in Investing Act... | -151.58 |
Of the Short Term Borrowings | -1,341.96 |
Of Financial Liabilities | -21.71 |
Dividend Paid | -263.64 |
Interest Paid | -209.72 |
Net Cash used in Financing Act... | -1,837.03 |
Company Details
Registered Office |
|
Address | Plot No 2 Maitrivihar, Behind Maithri Vanam Ameerpet |
City | Hyderabad |
State | Telangana |
Pin Code | 500038 |
Tel. No. | 91-40-23736370 |
Fax. No. | 91-40-23747340 |
cs@aurobindo.com; investorgrievances@aurobindo.com | |
Internet | http://www.aurobindo.com |
Registrars |
|
Address | Plot No 2 Maitrivihar |
City | Hyderabad |
State | Telangana |
Pin Code | 500038 |
Tel. No. | 91-40-23736370 |
Fax. No. | 91-40-23747340 |
cs@aurobindo.com; investorgrievances@aurobindo.com | |
Internet | http://www.aurobindo.com |
Management |
|
Name | Designation |
Kambam Nityananda Reddy | Vice Chairman & M.D. |
M Madan Mohan Reddy | Whole-time Director |
P V Ramprasad Reddy | Non Executive Director |
Savita Mahajan | Independent Director |
Girish Paman Vanvari | Independent Director |
P Sarath Chandra Reddy | Non Executive Director |
Santanu Mukherjee | Independent Director |
Deepali Pant Joshi | Independent Director |
M R Kumar | Chairman & Independent Directo |
Satakarni Makkapati | Non Executive Director |